CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
CO-CREATE-Ex:社区参与优化 COVID-19 快速评估和测试体验
基本信息
- 批准号:10617124
- 负责人:
- 金额:$ 102.31万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-11-01 至 2024-10-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAction ResearchAddressAdministratorAdoptionAreaAuthorization documentationCOVID-19COVID-19 impactCOVID-19 pandemicCOVID-19 testCOVID-19 testingCaliforniaClinicClinicalCommunitiesCommunity ParticipationCounselingCountyDiagnostic Reagent KitsDisparityFDA approvedFederally Qualified Health CenterGenerationsGoalsHealthHomeHumanIncidenceInstitutionInvestmentsKnowledgeLatinoLearningLinguisticsMapsMeasuresMethodsMexicoModelingOrganizational ChangeOutcomeParticipantPhasePopulationPositioning AttributePractical Robust Implementation and Sustainability ModelPreparationPreventive careProtocols documentationProviderPublic HealthRADx Underserved PopulationsReduce health disparitiesResearchResearch DesignResearch PersonnelSARS-CoV-2 infectionSelf AdministrationServicesSiteSocial ChangeSpecific qualifier valueTestingTheory of ChangeTrustWalkingWorkantigen testauthoritycare systemscommunity centercommunity organizationsethnic minorityevaluation/testingexperienceflexibilityhealth disparityhealth information technologyimplementation designimplementation evaluationimplementation measuresimplementation scienceimplementation strategyinnovationmemberminority communitiespandemic diseasepractical applicationprimary care clinicprimary outcomeprogramsprototypepublic health researchrapid testrapid testingresponsesafety netsecondary outcomeself testingsuccesstesting uptaketransmission processunderserved communityuptake
项目摘要
PROJECT SUMMARY/ABSTRACT
Cases of COVID-19 infection in San Diego have persistently remained high in the county’s central and southern
communities near the US/Mexico border, home to primarily Latino residents who have been one of the ethnic
minority communities most impacted by COVID-19. To address this, our Phase I RADx-UP project partnered
with San Ysidro Health (SYH), a federally qualified health center, and the Global Action Research Center (Global
ARC), a social change organization, to co-create and demonstrate the impact of a PCR-based COVID-19 testing
program in San Ysidro. To date, we have administered approximately 15,000 PCR tests for >10,000 community
members (92% Latino) and received requests from SYH to scale-out the testing program to additional primary
care clinic sites. Responsive to RFA-OD-22-006, we will continue working with our community (Global ARC) and
clinical (SYH) partners to refine, specify, implement, and evaluate an implementation strategy bundle that
optimizes COVID-19 testing, expanding beyond current PCR testing to focus on FDA-authorized COVID-19 rapid
antigen testing. Use of self-administered rapid antigen tests will allow participants to build capacity to self-test
and use health information technology to access additional clinic services. Based on initial implementation
mapping with the project’s established Community and Scientific Advisory Board, three implementation
strategies were prioritized to accelerate sustained uptake of rapid COVID-19 testing. These three strategies
include: (1) current, walk-up onsite free testing; (2) promotores-led COVID-19 test counseling and preventive
care reminders; (3) vending machines that dispense FDA-authorized self-testing kits. Our primary objectives are
to: 1) refine and operationalize our multi-component implementation strategy bundle and a related set of
measures of success for rapid FDA- authorized COVID-19 testing and 2) implement and evaluate impact of our
innovative, multilevel, and multicomponent implementation strategy bundle to optimize COVID-19 rapid testing
among underserved, Latino communities using a roll-out implementation optimization study design across four
clinics over 18 months. The COVID-19 pandemic has underscored the urgent and essential need to engage
invested community parties continuously and meaningfully in public health research to reduce health disparities.
This proposal is well-positioned to provide a set of strategies and measures of success that can be used in
settings serving underserved communities while maintaining flexibility to adjust to the changing COVID-19
landscape.
项目摘要/摘要
圣地亚哥的Covid-19病例在该县的中部和南部仍然很高
美国/墨西哥边境附近的社区,这里是主要拉丁裔居民的所在地
少数族裔社区受到19号共同影响最大的影响。为了解决这个问题,我们的I阶段Radx-Up项目合作
在联邦合格的健康中心和全球行动研究中心(全球)
Arc),一个社会变革组织,是为了共同创建和演示基于PCR的COVID-19测试的影响
在圣伊西德罗的计划。迄今为止,我们已经对> 10,000个社区进行了大约15,000个PCR测试
成员(拉丁裔为92%),并收到了SYH的请求,以扩大测试计划到其他主要
护理诊所地点。响应RFA-OD-22-006,我们将继续与社区(全球弧)和
临床(SYH)合作伙伴以完善,指定,实施和评估实施策略捆绑包
优化COVID-19测试,扩展超出当前PCR测试,专注于FDA授权的COVID-19
抗原测试。使用自我管理快速抗原测试将使参与者能够建立自我测试的能力
并使用健康信息技术访问其他诊所服务。基于初始实施
与该项目既定的社区和科学顾问委员会的映射,三个实施
优先考虑策略,以加速持续的Covid-19测试的持续吸收。这三个策略
包括:(1)当前,无现场测试; (2)启动子领导的Covid-19测试共同体和预防性
护理提醒; (3)分配FDA授权的自动测试套件的自动售货机。我们的主要目标是
至:1)完善和操作我们的多组分实施策略捆绑包和一组相关的集合
快速FDA授权COVID-19测试和2)实施和评估我们的影响的成功措施
创新,多级和多组分实施策略捆绑包,以优化COVID-19
在服务不足的拉丁裔社区中,使用了四个的推出实施优化研究设计
诊所超过18个月。 COVID-19大流行强调了参与的紧迫和基本需求
在公共卫生研究中不断地投资社区各方,以减少健康差异。
该提议的定位良好,以提供一套成功的策略和衡量标准
为服务不足的社区提供服务的设置,同时保持适应不断变化的Covid-19的灵活性
景观。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LOUISE CHANG LAURENT其他文献
LOUISE CHANG LAURENT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LOUISE CHANG LAURENT', 18)}}的其他基金
2023 RNA Nanotechnology Gordon Research Conference and Seminar
2023年RNA纳米技术戈登研究会议暨研讨会
- 批准号:
10598881 - 财政年份:2023
- 资助金额:
$ 102.31万 - 项目类别:
Administrative Supplement to U54 HD110347: Development of a Common Processing Pipeline and Visualization Tools for HuBMAP GeoMx Assays
U54 HD110347 的行政补充:用于 HuBMAP GeoMx 检测的通用处理流程和可视化工具的开发
- 批准号:
10825269 - 财政年份:2022
- 资助金额:
$ 102.31万 - 项目类别:
Bridging dataset generation to enable integrated data analysis and interpretation across HuBMAP tissues
桥接数据集生成以实现跨 HuBMAP 组织的集成数据分析和解释
- 批准号:
10672692 - 财政年份:2022
- 资助金额:
$ 102.31万 - 项目类别:
CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences
CO-CREATE-Ex:社区参与优化 COVID-19 快速评估和测试体验
- 批准号:
10845417 - 财政年份:2022
- 资助金额:
$ 102.31万 - 项目类别:
Pregnant Female Reproductive Tissue Mapping Center
孕妇生殖组织测绘中心
- 批准号:
10531089 - 财政年份:2022
- 资助金额:
$ 102.31万 - 项目类别:
Pregnant Female Reproductive Tissue Mapping Center
孕妇生殖组织测绘中心
- 批准号:
10670431 - 财政年份:2022
- 资助金额:
$ 102.31万 - 项目类别:
Female Reproductive Tissue Mapping Center Coordination Core
女性生殖组织绘图中心协调核心
- 批准号:
10268240 - 财政年份:2020
- 资助金额:
$ 102.31万 - 项目类别:
Female Reproductive Tissue Mapping Center Coordination Core
女性生殖组织绘图中心协调核心
- 批准号:
10119155 - 财政年份:2020
- 资助金额:
$ 102.31万 - 项目类别:
相似国自然基金
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
- 批准号:82371028
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
亚热带高密度城市居民的步行动态热舒适需求的影响因素与量化体系研究
- 批准号:52308121
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
YTHDF1通过m6A修饰调控耳蜗毛细胞炎症反应在老年性聋中的作用机制研究
- 批准号:82371140
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
成骨谱系功能异常在X-连锁显性低血磷性佝偻病/骨软化症发病中的作用与机制研究
- 批准号:82370888
- 批准年份:2023
- 资助金额:65.00 万元
- 项目类别:面上项目
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
- 批准号:82371248
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
相似海外基金
Assessing Clinical Effectiveness and Implementation of Worksite Sleep Health Coaching in Firefighters
评估消防员工作现场睡眠健康指导的临床效果和实施情况
- 批准号:
10585123 - 财政年份:2023
- 资助金额:
$ 102.31万 - 项目类别:
Novel Bioresorbable Vascular Scaffolds with Uniform Biodegradation
具有均匀生物降解性的新型生物可吸收血管支架
- 批准号:
10930188 - 财政年份:2023
- 资助金额:
$ 102.31万 - 项目类别:
Contributions of autophagy-related genes in lupus
自噬相关基因在狼疮中的贡献
- 批准号:
10682136 - 财政年份:2023
- 资助金额:
$ 102.31万 - 项目类别:
Autonomic Dysfunction in Patients with HFpEF
HFpEF 患者的自主神经功能障碍
- 批准号:
10587484 - 财政年份:2023
- 资助金额:
$ 102.31万 - 项目类别: